Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, April 13, 2018

iHOPE: Getting a Grip on Spasticity webinar; Steve Page PhD, MOT, MS, OTR/L


Good descriptions but zero mention of cures. Doesn't mention  these spasticity treatments;

Effect of shock wave therapy on ankle plantar flexors spasticity in stroke patients

A single group, pretest-posttest clinical trial for the effects of dry needling on wrist flexors spasticity after stroke

Brain stimulation protocol reduces spasticity in spinal cord injury patients

S2-3 Improvements in spasticity and motor function using a foot bath for people with chronic hemiparesis following stroke

Oromucosal Spray Improves Tough-to-Treat Spasticity in Patients With MS

Apparatus for reduction of spasticity in male and female patients having spinal cord injury as well as obtaining semen from males by stimulation of ejaculatory nerves 

Neuromuscular Electrical Stimulation and Dynamic Bracing as a Treatment for Upper-Extremity Spasticity in Children with Cerebral Palsy

Neuromuscular Electrical Stimulation with Dorsum hand splint enhance rehabilitation of spastic hand in stroke patients

A single blind, clinical trial to investigate the effects of a single session extracorporeal shock wave therapy on wrist flexor spasticity after stroke

Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis

 

 page 23 and on shows management of spasticity, not cures. 46 minutes
  • Defining spasticity and how it develops
  • Why does spasticity matter? Why should I care about spasticity?
  • Explaining contractures are
  • Impacts of spasticity
  • Treatment options
  • Members of the Care Team
Steve Page, PhD, is a licensed occupational therapist at Ohio State University Medical Center. Dr. Page develops and tests therapies to increase function and independence after stroke and other neurological diseases. He is widely published and is in demand nationally and internationally as a speaker and presenter. In additional to his responsibilities as an associate professor at Ohio State, Dr. Page volunteers his time to develop informational products and seminars targeting clinicians and stroke survivors. He also maintains a clinical practice treating stroke survivors and others with neurological disorders.


Tell us about your experience. A new window with a short survey will pop up after you close out of the webinar. Please take a few minutes to give us your feedback. This webinar was recorded
July 24, 2013.

All webinars are prerecorded except where noted.

System requirements:
PC-based attendees - Required: Windows® 2000, XP Home, XP Pro, 2003 Server, Vista or newer.
Macintosh®-based attendees - Required: Mac OS X 10.4 (Tiger®) or newer

This program is funded by Allergan, Inc., AstraZeneca Pharmaceuticals, Avanir Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Bristol-Myers Squibb and Pfizer, Inc., Genentech, Inc., the Melvin and Elaine Wolf Foundation, MetLife Foundation, NovaVision, Pfizer, Inc. and Purdue Pharma.
Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)